

![]() |
Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry |
|
Authors | ||
Published in | Joint, Bone, Spine. 2013, vol. 80, no. 2, p. 160-4 | |
Abstract | In Switzerland, the prescription of biologic antirheumatic agents in rheumatoid arthritis (RA) patients is not limited by stringent requirements from health authorities. The goals of this study were to: determine the characteristics of the Swiss patients at the initiation of biologics, compare them with other countries and evaluate whether different disease activity levels at initiation of therapy, resulting from distinct access to these treatment, influence their effectiveness. | |
Keywords | Adult — Aged — Antirheumatic Agents/therapeutic use — Arthritis, Rheumatoid/drug therapy/epidemiology/physiopathology — Biological Therapy — Cross-Cultural Comparison — Europe/epidemiology — Female — Humans — Male — Middle Aged — Registries/statistics & numerical data — Retrospective Studies — Switzerland/epidemiology — Treatment Outcome | |
Identifiers | PMID: 22771133 | |
Full text | ||
Structures | ||
Research group | Mécanisme de l'inflammation articulaire (44) | |
Citation (ISO format) | ZUFFEREY, Pascal et al. Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry. In: Joint, Bone, Spine, 2013, vol. 80, n° 2, p. 160-4. doi: 10.1016/j.jbspin.2012.05.003 https://archive-ouverte.unige.ch/unige:46012 |